On November 29th, Hao Deming, Vice President and Secretary General of the Standing Committee of the China Association of Non Public Medical Institutions, Mao Yan, Deputy Director of the Talent Technology Service Department, and Zhao Lisha, Deputy Secretary General of the Regenerative Medicine Branch (preparatory), visited Shenzhen Cell Valley for research. Our Chairman Professor Shi Yuanyuan, Vice General Manager Tang Xiaomeng, Business Director Wei Zheng, Marketing Department Minister Sun Rui, Business Department Head Tang Hui, and Office Director Wang Lu warmly received and held a symposium.


Under the detailed introduction of Business Director Wei Zheng, the visiting leaders visited the digital intelligence exhibition hall of Shenzhen Cell Valley and gained a deeper understanding of the strategic deployment, unique core technologies, and future development trends of Cell Valley. Subsequently, I delved into research and development, production, and quality management laboratories, gaining a more intuitive understanding of the actual operational processes and quality management system.

At the symposium, Professor Shi Yuanyuan first warmly welcomed the visiting leaders and expressed sincere gratitude for their arrival. Subsequently, Minister Sun Rui gave a detailed introduction to the current situation of the cell therapy industry, the industrial layout of Shenzhen Cell Valley in cell and gene therapy, and scientific research products.
Professor Shi Yuanyuan stated that recently, many regions have issued policies to promote the cell therapy industry, and cell therapy, as a billion dollar health industry, has entered an accelerated development period. Shenzhen Cell Valley will closely follow policy development trends, provide comprehensive services for product research and development and achievement transformation, fully utilize advanced technology and talent reserves, assist in the construction of the cell and gene therapy industry chain, and make positive contributions to promoting the high development of the domestic cell and gene therapy industry.
President Hao Deming further introduced at the symposium that the China Association of Non Public Medical Institutions is located in Beijing. As a national, industry, and non-profit independent legal entity, it is the only national level industry organization in China engaged in non-public medical and health institution industry services and industry management. At present, the association has over 500000 medical institutions and 26000 hospitals nationwide, accounting for 70% of the total number of hospitals in China. It has become the largest and most influential national level medical and health institution industry association in China and even globally.
The purpose of this exchange is to understand the national policy orientation, grasp the development trend of the industry, clarify the development direction of the industry, and explore the potential roles and cooperation opportunities of non-public medical institutions in the field of cell therapy through communication with member institutions of the China Association of Non Public Medical Institutions. Together, we can promote the healthy development of China's cell therapy industry.
Take a group photo as a souvenir